Experience

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Natera, Inc. of $287.5 million aggregate principal amount of its 2.25%…

Davis Polk advised the joint book-running managers on an SEC-registered offering by Valero Energy Corporation of $1.5 billion aggregate principal amount of its 2.700% senior notes due…

Davis Polk advised Exxon Mobil Corporation on the SEC-registered offering of $2.75 billion principal amount of 1.571% notes due 2023, $1.25 billion principal amount of 2.992% notes due 2025…

Davis Polk advised Pattern Energy Group Inc. in connection with the solicitation of consents from holders of its existing 5.875% senior notes due 2024 for certain amendments to the…

Davis Polk advised our client McKesson, working with four other medical equipment suppliers, in obtaining antitrust clearance to work collaboratively to increase the supply of personal…

Davis Polk advised Mitsubishi UFJ Lease & Finance Company Limited on its Rule 144A/Regulation S offering of senior notes, which consisted of $450 million aggregate principal amount of 3…

Davis Polk advised the joint book-running managers and representatives of the underwriters on an SEC-registered offering by Caterpillar Inc. of $2 billion aggregate principal amount of…

Davis Polk advised the joint book-running managers in connection with a Rule 144A/Regulation S offering of $600 million aggregate principal amount of 3.395% senior notes due 2030 by…

Davis Polk advised the underwriters on an SEC-registered offering by Baidu, Inc. of its $600 million 3.075% notes due 2025 and $400 million 3.425% notes due 2030.Baidu, Inc. is a…

Davis Polk represented PENTAX Medical, a global medical device manufacturer that is a division of HOYA Group, in a criminal investigation into potential misbranding of its endoscope devices…